| 1 |
31258693 | Overexpression of microRNA-620 facilitates the resistance of triple negative breast cancer cells to gemcitabine treatment by targeting DCTD. | 2019 Jul |
3 |
| 2 |
28912488 | Gene Expression and Methylation Analyses Suggest DCTD as a Prognostic Factor in Malignant Glioma. | 2017 Sep 14 |
4 |
| 3 |
22838949 | Pathway-based pharmacogenomics of gemcitabine pharmacokinetics in patients with solid tumors. | 2012 Jul |
1 |
| 4 |
16551864 | Gemcitabine pharmacogenomics: cytidine deaminase and deoxycytidylate deaminase gene resequencing and functional genomics. | 2006 Mar 15 |
3 |
| 5 |
16708051 | Ribonucleotide reductase M1 (RRM1) 2464G>A polymorphism shows an association with gemcitabine chemosensitivity in cancer cell lines. | 2006 Jun |
2 |